Aortic valve replacement with the Toronto SPV: long-term clinical and hemodynamic results

255 patients undergoing aortic valve replacement (mean age 63+/-11 years, 181 males, 74 females). Preoperative diagnoses included aortic stenosis (76%), aortic insufficiency (12%), and mixed lesion (12%). NYHA class III and IV were present in 49% preoperatively.

Aortic valve replacement with the Toronto stentless porcine valve (SPV) bioprosthesis

Long-term clinical and echocardiographic outcomes including actuarial survival, freedom from cardiac death, valve-related death, valve reoperation, structural valve degeneration, thromboembolism, endocarditis, and transvalvular pressure differences at 7 yearshard clinical